| Filed On | Filing |
|---|---|
| 12 Nov 2025 |
Form 4: Rademaker Craig Evan, Director
Granted 92,104 Director Stock Option |
| 12 Nov 2025 |
Form 4: Soffer David Spencer, Director
Granted 51,000 Director Stock Option |
| 12 Nov 2025 |
Form 4: Kuendig Thomas Martin, Director
Granted 79,115 Director Stock Option |
| 12 Nov 2025 |
Form 4: Troy Tevi David, Director
Granted 56,000 Director Stock Option |
| 19 Mar 2025 |
Form 4: Simard John, Director
Granted 1,026,228 Stock Option |
| 04 Feb 2025 |
Form 4: Simard John, Director
Disposed of 2,470,355 Convertible Loan Agreement (Other Transaction) ($24.7T) |
| 21 Jun 2024 |
Form 4: Mckenzie W Thorpe, Director
Granted 37,500 Director Stock Option |
| 21 Jun 2024 |
Form 4: Waldin Jan-Paul, Director
Granted 37,500 Director Stock Option |
| 21 Jun 2024 |
Form 4: MacAdam Donald H., Director
Granted 37,500 Director Stock Option |
| 21 Jun 2024 |
Form 4: Libby Peter, Director
Granted 37,500 Director Stock Option |
| 05 Jan 2024 |
Form 4: Simard John, Director
Acquired 2,470,355 Convertible Loan Agreement (Open Market Purchase) ($24.7T) |
| 26 Jun 2023 |
Form 4: Waldin Jan-Paul, Director
Granted 25,000 Director Stock Option |
| 26 Jun 2023 |
Form 4: Libby Peter, Director
Granted 25,000 Director Stock Option |
| 26 Jun 2023 |
Form 4: MacAdam Donald H., Director
Granted 25,000 Director Stock Option |
| 26 Jun 2023 |
Form 4: Mckenzie W Thorpe, Director
Granted 25,000 Director Stock Option |
| 17 Feb 2023 |
Form 4: Shivaswamy Sushma, Chief Scientific Officer
Granted 100,000 Employee Stock Option (right to buy) |
| 27 Jun 2022 |
Form 4: MacAdam Donald H., Director
Granted 25,000 Stock Option |
| 27 Jun 2022 |
Form 4: Mckenzie W Thorpe, Director
Granted 25,000 Stock Option |
| 27 Jun 2022 |
Form 4: Waldin Jan-Paul, Director
Granted 25,000 Stock Option |
| 27 Jun 2022 |
Form 4: Libby Peter, Director
Granted 25,000 Director Stock option |
Loading...